About
Besides being co-founder, majority shareholder and Chairman of Innogenetics, Rudi Mariën (Belgium) is also the founder, shareholder and Managing Director of several clinical reference laboratories. He holds additional board positions in different stock-listed and private biotech companies. Rudi was the founder, shareholder and Managing Director of the Barc Group, a leading international centralized clinical laboratory, exclusively dedicated to pharmaceutical studies. Currently he is Vice President of Cerba European Lab (European network of medical labs) and President & Managing Director of Gengest Bvba and Biovest CVA. Through his management company, Gengest BVBA, Rudi also holds board positions in different stock-listed and private biotech companies. Rudi holds a degree in pharmaceutical sciences from the University of Gent and is specialized in clinical biology.
Position in the VCSift Database
- • 398 investors hold the Chairman role in VCSift. Rudi M. Marien is one of them.
- • 48 investors are based in Belgium.
Data sourced from 410,343 investor profiles. Updated July 2026.
Contact Information
Find more investors like Rudi M.
Search Investors